Inhoudsopgave
Advertenties
Referenties
1.
Schade DS, Eaton RP. Metabolic and clinical significance of ketosis. Special Topics in
Endocrinology and Metabolism 1982; 4:1–27.
2.
Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Treatment of
diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the
endpoint of emergency management. Diabetes Care 1997; 20:1347–1352.
3.
Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A, Uno S, Shigeta Y. Ketone bodies as
markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetes
control. Diabetologia 1984; 26:343-348.
4.
Ubukata E. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus
and non-insulin-dependent diabetes mellitus patients: The relationship to serum C-peptide
immunoreactivity and free insulin. Ann Nutr Metab 1990; 34:333–342.
5.
Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin
therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37:1470–1477.
6.
Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic
ketoacidosis. Br Med J 1984; 289; 1035–1038.
7.
Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning
the approximation of the laws, regulations and administrative provisions of the Member States
relating to the classification, packaging and labelling of dangerous preparations.
45
ART20312_Rev-B-Guide.indd 45
7/6/11 9:25 AM
Advertenties
Inhoudsopgave
